SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-127056
Filing Date
2024-11-14
Accepted
2024-11-14 16:10:09
Documents
12
Period of Report
2024-11-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K alec-20241114.htm   iXBRL 8-K 47696
2 EX-99.1 alec-ex99_1.htm EX-99.1 14720
  Complete submission text file 0000950170-24-127056.txt   181820

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT alec-20241114.xsd EX-101.SCH 24837
14 EXTRACTED XBRL INSTANCE DOCUMENT alec-20241114_htm.xml XML 4686
Mailing Address 131 OYSTER POINT BLVD., SUITE 600 SOUTH SAN FRANCISCO CA 94080
Business Address 131 OYSTER POINT BLVD., SUITE 600 SOUTH SAN FRANCISCO CA 94080 415-231-5660
Alector, Inc. (Filer) CIK: 0001653087 (see all company filings)

IRS No.: 822933343 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38792 | Film No.: 241462188
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)